Robert S. Radie

Robert S. Radie (board member) discloses dealings in 3 companies, chiefly Egalet Corp, Paratek Pharmaceuticals, Inc. and Rockwell Medical, Inc. We count 39 filings; the first trade dates from 4 January 2016 and the latest from 1 July 2026.

Every open-market trade on record is a sale: 15 sales worth €455k. Besides market trades, the filings include 19 share grants and 2 option exercises.

The newest entry dates from 6 July 2026: a share grant, in Rockwell Medical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.